Division of Nephrology, Kidney Institute of CPLA, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Third Hospital of Xi'an, Department of Anesthesiology, Xi'an, China.
Kidney Blood Press Res. 2019;44(5):879-896. doi: 10.1159/000502546. Epub 2019 Sep 25.
The different clinical characteristics of community-acquired acute kidney injury (CA-AKI) versus hospital-acquired AKI (HA-AKI) have remained inconclusive, and thus, a meta-analysis was conducted to summarize and quantify the clinical significance distinguishing the 2 types of AKI.
We identified observational studies reporting the clinical characteristics and prognosis of HA-AKI and CA-AKI. ORs and mean differences (MDs) were extracted for each outcome and the results aggregated. The primary outcome was defined as the mortality rate; renal recovery, oliguria incidence, dialysis, intensive care unit (ICU) requirement, and length of hospital stay were secondary outcomes.
Fifteen eligible studies involving 46,157 patients (22,791 CA-AKI patients and 23,366 HA-AKI patients) were included. Mortality was significantly lower in CA-AKI than in HA-AKI patients, with an OR of 0.43 (95% CI 0.35-0.53). The incidence of oliguria and need for ICU were also lower in CA-AKI patients (OR 0.58, 95% CI 0.38-0.88; OR 0.24, 95% CI 0.14-0.40, respectively). CA-AKI patients had a shorter hospital stay (MD -9.42, 95% CI -13.73 to -5.12). The renal recovery rate and dialysis need between CA- and HA-AKI were similar (OR 1.27, 95% CI 0.53-3.02; OR 1.05, 95% CI 0.82-1.34, respectively).
CA-AKI showed better clinical manifestations with a lower incidence of oliguria, reduced risk of ICU treatment, and shorter hospital stay. Mortality associated with CA-AKI was lower compared with HA-AKI, indicating a better prognosis. The rate of renal recovery and need for dialysis showed no significant difference between the 2 groups.
社区获得性急性肾损伤 (CA-AKI) 与医院获得性 AKI (HA-AKI) 的临床特征不同,但仍存在争议,因此进行了荟萃分析以总结和量化区分这两种 AKI 的临床意义。
我们确定了报告 HA-AKI 和 CA-AKI 临床特征和预后的观察性研究。对于每个结局,提取比值比 (OR) 和均值差异 (MD) 并进行汇总。主要结局定义为死亡率;肾恢复、少尿发生率、透析、重症监护病房 (ICU) 需求和住院时间为次要结局。
纳入了 15 项符合条件的研究,共涉及 46157 名患者(22791 例 CA-AKI 患者和 23366 例 HA-AKI 患者)。CA-AKI 患者的死亡率明显低于 HA-AKI 患者,OR 为 0.43(95%CI 0.35-0.53)。CA-AKI 患者的少尿发生率和 ICU 需求也较低(OR 0.58,95%CI 0.38-0.88;OR 0.24,95%CI 0.14-0.40)。CA-AKI 患者的住院时间更短(MD-9.42,95%CI-13.73 至-5.12)。CA-AKI 和 HA-AKI 患者的肾恢复率和透析需求相似(OR 1.27,95%CI 0.53-3.02;OR 1.05,95%CI 0.82-1.34)。
CA-AKI 表现出更好的临床表现,少尿发生率较低,ICU 治疗风险降低,住院时间更短。与 HA-AKI 相比,CA-AKI 相关死亡率较低,提示预后较好。两组之间的肾恢复率和透析需求无显著差异。